Henrique de Almeida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Henrique de Almeida has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aldaíza Ribeiro
Albert Sabin Children Hospital, Fortaleza 60410-794, Brazil
1 shared publication - Bruno Nascimento da Silva
Department of Pathology and Legal Medicine, Federal University of Ceará, Fortaleza 60430-160, Brazil
1 shared publication - Denis Francisco Gonçalves De Oliveira
Postgraduate Program in Morphofunctional Sciences, Department of Morphology, Faculty of Medicine, Federal University of Ceará, Fortaleza, Brazil
1 shared publication - Débora de Souza Collares Maia Castelo-Branco
Federal University of Ceará
1 shared publication - Edlâny Milanez
Department of Pathology and Legal Medicine, Federal University of Ceará, Fortaleza 60430-160, Brazil
1 shared publication - Fernando Victor Portela
Department of Pathology and Legal Medicine, Federal University of Ceará, Fortaleza 60430-160, Brazil
1 shared publication
Latest Publications
- Open Access
- 13 August 2023
- Published by MDPI AG in Journal of Fungi
- Vol. 9 (8) , 844
Clinical, Epidemiological and Laboratory Features of Invasive Candida parapsilosis Complex Infections in a Brazilian Pediatric Reference Hospital during the COVID-19 Pandemic
The present study aimed to describe the clinical, epidemiological and laboratory characteristics of invasive candidiasis by C. parapsilosis complex (CPC) in a Brazilian tertiary pediatric hospital during the COVID-19 pandemic. Clinical samples were processed in the BACT/ALERT® 3D system or on agar plates. Definitive identification was achieved by MALDI-TOF MS. Antifungal susceptibility was initially analyzed by the VITEK 2 system (AST-YS08 card) and confirmed by the CLSI protocol. Patient data were collected from the medical records using a structured questionnaire. CPC was recovered from 124 patients over an 18-month period, as follows: C. parapsilosis (83.87%), C. orthopsilosis (13.71%) and C. metapsilosis (2.42%). Antifungal resistance was not detected. The age of the patients with invasive CPC infections ranged from C. parapsilosis. C. orthopsilosis infections were significantly more prevalent in patients from critical care units. Invasive infections caused by different pathogens occurred in 75 patients up to 30 days after the recovery of CPC isolates. Overall, 23 (18.55%) patients died within 30 days of CPC diagnosis. Catheter removal and antifungal therapy were important measures to prevent mortality. COVID-19 coinfection was only detected in one patient.
- 13 August 2023
- Published by MDPI AG in Journal of Fungi
- Vol. 9 (8) , 844
Open AccessClinical, Epidemiological and Laboratory Features of Invasive Candida parapsilosis Complex Infections in a Brazilian Pediatric Reference Hospital during the COVID-19 Pandemic
The present study aimed to describe the clinical, epidemiological and laboratory characteristics of invasive candidiasis by C. parapsilosis complex (CPC) in a Brazilian tertiary pediatric hospital during the COVID-19 pandemic. Clinical samples were processed in the BACT/ALERT® 3D system or on agar plates. Definitive identification was achieved by MALDI-TOF MS. Antifungal susceptibility was initially analyzed by the VITEK 2 system (AST-YS08 card) and confirmed by the CLSI protocol. Patient data were collected from the medical records using a structured questionnaire. CPC was recovered from 124 patients over an 18-month period, as follows: C. parapsilosis (83.87%), C. orthopsilosis (13.71%) and C. metapsilosis (2.42%). Antifungal resistance was not detected. The age of the patients with invasive CPC infections ranged from C. parapsilosis. C. orthopsilosis infections were significantly more prevalent in patients from critical care units. Invasive infections caused by different pathogens occurred in 75 patients up to 30 days after the recovery of CPC isolates. Overall, 23 (18.55%) patients died within 30 days of CPC diagnosis. Catheter removal and antifungal therapy were important measures to prevent mortality. COVID-19 coinfection was only detected in one patient.